Paper20164575
Grb2-mediated alteration in the trafficking of AbetaPP: insights from Grb2-AICD interaction.
Raychaudhuri M and 1 other. J Alzheimers Dis, 2010. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Grb2-mediated alteration in the trafficking of AbetaPP: insights from Grb2-AICD interaction. Papers, record 20164575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20164575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Grb2-mediated alteration in the trafficking of AbetaPP: insights from Grb2-AICD interaction.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid beta-Protein Precursor | Major topic |
| GRB2 Adaptor Protein | Major topic |
| Protein Interaction Domains and Motifs | Major topic |
| Cell Line, Tumor | |
| Centrosome | |
| Exosomes | |
| Gene Expression Regulation | |
| Humans | |
| Immunoprecipitation | |
| Luminescent Proteins | |
| Lysosomal-Associated Membrane Protein 2 | |
| Neuroblastoma | |
| Protein Transport | |
| RNA Interference | |
| Signal Transduction | |
| Tetrazolium Salts | |
| Thiazoles | |
| Time Factors | |
| Transfection | |
| rab GTP-Binding Proteins | |
| rab5 GTP-Binding Proteins | |
| rab7 GTP-Binding Proteins |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39980902 | Whole Genome Variable Number Tandem Repeat Analysis in Alzheimer Disease. | Neurol Genet | 2025 | https://conductscience.org/library/papers/39980902 | PubMed |
| 39143264 | A Holistic Analysis of Alzheimer's Disease-Associated lncRNA Communities Reveals Enhanced lncRNA-miRNA-RBP Regulatory Triad Formation Within Functionally Segregated Clusters. | J Mol Neurosci | 2024 | https://conductscience.org/library/papers/39143264 | PubMed |
| 35882892 | Vav2 is a novel APP-interacting protein that regulates APP protein level. | Sci Rep | 2022 | https://conductscience.org/library/papers/35882892 | PubMed |
| 34409981 | A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes. | Biochem J | 2021 | https://conductscience.org/library/papers/34409981 | PubMed |
| 31154588 | Receptor tyrosine kinases (RTKs) consociate in regulatory clusters in Alzheimer's disease and type 2 diabetes. | Mol Cell Biochem | 2019 | https://conductscience.org/library/papers/31154588 | PubMed |
| 28360125 | Cellular levels of Grb2 and cytoskeleton stability are correlated in a neurodegenerative scenario. | Dis Model Mech | 2017 | https://conductscience.org/library/papers/28360125 | PubMed |
| 24116161 | Grb2 is regulated by foxd3 and has roles in preventing accumulation and aggregation of mutant huntingtin. | PLoS One | 2013 | https://conductscience.org/library/papers/24116161 | PubMed |
| 23084776 | Novel adaptors of amyloid precursor protein intracellular domain and their functional implications. | Genomics Proteomics Bioinformatics | 2012 | https://conductscience.org/library/papers/23084776 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GRB2 | 2885 | PubTator's text mining | https://conductscience.org/library/genes/2885 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20164575
GET https://conductscience.org/api/papers/v1/20164575/authors